Clearside Biomedical, Inc. (CLSDQ) — 10-Q Filings
All 10-Q filings from Clearside Biomedical, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Clearside's Cash Dwindles Amid Strategic Review, R&D Pause
— Nov 14, 2025 Risk: high
Clearside Biomedical, Inc. reported a net loss of $5.97 million for the three months ended September 30, 2025, an improvement from a $7.69 million net loss in t -
Clearside Narrows Q2 Loss Amidst Revenue Dip, R&D Cuts
— Aug 8, 2025 Risk: high
Clearside Biomedical, Inc. reported a net loss of $10.1 million for the three months ended June 30, 2025, compared to a net loss of $10.7 million for the same p -
Clearside Biomedical Files Q1 2025 10-Q
— May 15, 2025 Risk: medium
Clearside Biomedical, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. Key events inc -
Clearside Biomedical Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
Clearside Biomedical, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the thi -
Clearside Biomedical Files Q2 2024 10-Q
— Aug 12, 2024 Risk: medium
Clearside Biomedical, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial performance and business operations. Key ev -
Clearside Biomedical, Inc. Files 10-Q for Period Ending March 31, 2024
— May 10, 2024 Risk: medium
Clearside Biomedical, Inc. (CLSDQ) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Clearside Biomedical, Inc. filed a 10-Q report for the period e
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX